XML 29 R24.htm IDEA: XBRL DOCUMENT v2.4.0.8
Stockholders' Equity (Stock Option Activity) (Details) (USD $)
In Thousands, except Share data, unless otherwise specified
6 Months Ended 12 Months Ended
Jun. 29, 2014
Dec. 29, 2013
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]    
Outstanding, Beginning Balance (in shares) 13,938,487  
Granted (in shares) 521,650  
Exercised (in shares) (1,454,437)  
Canceled (in shares) (4,147)  
Forfeited (in shares) (266,111)  
Outstanding, Ending Balance (in shares) 12,735,442 13,938,487
Vested and expected to vest (in shares) 12,445,248  
Exercisable (in shares) 9,005,173  
Share-based Compensation Arrangement by Share-based Payment Award, Options, Weighted Average Exercise Price [Abstract]    
Weighted Average Exercise Price, Outstanding, Beginning Balance (in dollars per share) $ 7.40  
Weighted Average Exercise Price, Granted (in dollars per share) $ 42.60  
Weighted Average Exercise Price, Exercised (in dollars per share) $ 1.05  
Weighted Average Exercise Price, Canceled (in dollars per share) $ 6.89  
Weighted Average Exercise Price, Forfeited (in dollars per share) $ 12.26  
Weighted Average Exercise Price, Outstanding, Ending Balance (in dollars per share) $ 9.47 $ 7.40
Weighted Average Exercise Price, Vested and expected to vest (in dollars per share) $ 9.30  
Weighted Average Exercise Price, Exercisable (in dollars per share) $ 7.37  
Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract]    
Weighted Average Remaining Contractual Term, Outstanding, Beginning Balance 8 years 3 months 18 days 8 years 6 months 22 days
Weighted Average Remaining Contractual Term, Vested and expected to vest 8 years 4 months 17 days  
Weighted Average Remaining Contractual Term, Exercisable 8 years 4 months 10 days  
Weighted Average Remaining Contractual Term, Outstanding, Ending Balance 8 years 3 months 18 days 8 years 6 months 22 days
Total Intrinsic Value, Outstanding $ 374,453 $ 462,558
Total Intrinsic Value, Vested and expected to vest 367,820  
Total Intrinsic Value, Exercisable $ 282,126